Introduction
prostate cancer
EVENTS, PROSTATE CANCER
The relationship between testosterone replacement therapy (TRT) and the risk of prostate cancer remains incompletely studied.In 2015, the US Food and Drug Administration required testosterone manufacturers to conduct a randomized clinical trial to determine the effect of TRT on major adverse cardiovascular events (MACEs).